|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,530.00 ARS | -0.65% |
|
-0.65% | -22.53% |
| Market Cap | 124B 82.45M 72.48M 67.47M 61.96M 116M 7.91B 118M 802M 313M 3.9B 310M 303M 13.49B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 355B 237M 208M 194M 178M 334M 22.69B 338M 2.3B 899M 11.21B 888M 869M 38.73B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | -0.65% | ||
| 1 week | -0.65% | ||
| Current month | -2.55% | ||
| 1 month | -4.38% | ||
| 3 months | -4.08% | ||
| 6 months | -23.88% | ||
| Current year | -22.53% |
| 1 week | 1,495 | 1,595 | |
| 1 month | 1,495 | 1,615 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 2025-04-28 | |
| Corporate Officer/Principal | - | 2025-04-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.65% | -0.65% | +11.27% | +194.23% | 83.22M | ||
| +0.13% | +4.41% | +47.35% | +163.20% | 1,067B | ||
| +0.97% | +6.88% | +58.02% | +53.12% | 635B | ||
| -0.94% | +1.39% | +35.02% | +72.60% | 458B | ||
| +1.41% | +8.56% | +38.93% | +32.17% | 347B | ||
| +1.28% | +4.40% | +38.42% | +41.62% | 295B | ||
| +1.72% | +4.10% | +19.31% | +20.45% | 262B | ||
| +1.84% | -0.46% | -27.78% | -38.65% | 216B | ||
| +0.06% | +3.32% | +22.73% | +59.40% | 203B | ||
| +0.94% | -2.02% | +12.32% | +70.59% | 161B | ||
| Average | +0.68% | +1.76% | +25.56% | +66.87% | 364.36B | |
| Weighted average by Cap. | +0.60% | +2.25% | +36.75% | +78.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 61.26M 53.85M 50.13M 46.04M 86.45M 5.87B 87.59M 596M 233M 2.9B 230M 225M 10.03B | 127B 84.57M 74.34M 69.2M 63.56M 119M 8.11B 121M 823M 321M 4B 317M 311M 13.84B |
| Net income | 23.85B 15.91M 13.99M 13.02M 11.96M 22.46M 1.53B 22.75M 155M 60.45M 754M 59.73M 58.45M 2.6B | 3.09B 2.06M 1.81M 1.69M 1.55M 2.91M 198M 2.95M 20.04M 7.83M 97.58M 7.74M 7.57M 337M |
| Net Debt | 134B 89.19M 78.4M 72.98M 67.03M 126M 8.55B 128M 868M 339M 4.22B 335M 328M 14.6B | 231B 154M 136M 126M 116M 218M 14.79B 220M 1.5B 586M 7.3B 579M 566M 25.23B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | ARS 1,530.00 | -0.65% | 34,559 |
| 26-07-24 | ARS 1,540.00 | -0.65% | 13,826 |
| 26-07-23 | ARS 1,550.00 | +0.32% | 32,355 |
| 26-07-22 | ARS 1,545.00 | +1.31% | 855 |
| 26-07-21 | ARS 1,525.00 | -0.97% | 1,204 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















